Floatz logo

(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE

Healthy Volunteers

National Institute of Mental Health (NIMH)Small moleculePhase 4 / ApprovedActive
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
81/ 100

Competitive context

64 Active assets in the Healthy Volunteers cohort.

Asset / SponsorPhaseRating
Semaglutide
Novo Nordisk A/S
Phase 4BB
DULAGLUTIDE
Novo Nordisk A/S
Phase 4BB
Alpha-1-Proteinase Inhibitor
Baxalta now part of Shire
Phase 4BB
1-(18F)Fluoranyl-3-[[2-[(E)-4-[6-(methylamino)pyridin-3-yl]but-1-en-3-ynyl]-1,3-benzothiazol-6-yl]oxy]propan-2-ol
APRINOIA Therapeutics, LLC
Phase 3BB
Risperdal
University of Manchester
Phase 4BB

View all 50 →

Same molecule, other indications

(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE is also rated in:

major depressive disorderDormant
BBB
Indicative ·
74 / 100
View asset →
major depressive disorderDormant
BBB
Indicative ·
74 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →